Protas, Duke and CTTI on clinical trials for diverse populations in the US
A new article by Protas, Duke and CTTI explores how clinical trials can generate better evidence.
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
A new article by Protas, Duke and CTTI explores how clinical trials can generate better evidence.
As part of New Scientist’s 2023 campaign on innovation in clinical research and development, Prof Sir Martin Landray explores the pressing need to transform clinical…